Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase
Infectious Diseases Hepatitis B Virus
- Results
-
Download -
Study results
LPS_NV25361_final results_March2021_Chinese
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_English
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_Italian
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_Spanish_Latin America
(PDF, 0.6 MB)
LPS_NV25361_final results_July2021_Dutch
(PDF, 0.6 MB)
LPS_NV25361_final results_July2021_French_Belgium
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_Turkish
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_German
(PDF, 0.6 MB)
LPS_NV25361_final results_March2021_Romanian
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com